Sambit Majumdar, Amity University Kolkata
Metastatic cancer is a sort of cancer that spread to different parts of the body from where it’s started. Metastatic kidney cancer often spreads to the lungs, brain, bones, and other parts of the body. The 3 CheckMate 9ER trial has provided a first-line treatment for patients with this sort of cancer.
A recent treatment trial is published by the European Society of Medical Oncology (ESMO), during which they used two sorts of the drug for trials as mono-therapies within the second line nivolumab and cabozantinib and combined them to be used as a first-line treatment counter to sunitinib. The compound came intent on loftier in the survival of the patient without getting worse. This has received a stronger repose rate in various age groups, sex, PD-L1 expression, and IMDC risk group.
The Director of Dana-Farber Cancer Institute and also the Jerome and Nancy Kohlberg Chair and Professor of medication, Harvard School of medicine, Boston, USA said that the results with this compound therapy were statistically significant and clinically meaningful and risk of progression and death was almost cut by 50% and 40% respectively, and also the response rate doubled.
Suggested Report:
https://medicalxpress.com/news/2020-09-first-line-treatment-option-metastatic-kidney.html
Paper to Read: https://pubmed.ncbi.nlm.nih.gov/30173085/
For more updates please visit- https://bioxone.in//
Can E.coli combat ionizing radiation?
-Anuska Sen,Team bioXone Ionizing radiation (IR) is known to have numerous ill-effects and can even be fatal to most organisms on exposure at high concentrations. Scientists are continuously in search of organisms or strains of bacteria that are resistant to such radiation, meaning which possess the property of “radio-resistance”. Till date, it was known that […]